Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Barriers to non-HDL cholesterol goal attainment by providers.
Virani SS, Steinberg L, Murray T, Negi S, Nambi V, Woodard LD, Bozkurt B, Petersen LA, Ballantyne CM.
Am J Med. 2011 Sep;124(9):876-80.e2.
Related citations
Activating peripheral arterial disease patients to reduce cholesterol: a randomized trial.
McDermott MM, Reed G, Greenland P, Mazor KM, Pagoto S, Ockene JK, Graff R, Merriam PA, Leung K, Manheim L, Kibbe MR, Olendzki B, Pearce WH, Ockene IS.
Am J Med. 2011 Jun;124(6):557-65.
Cardiovascular risk factors in patients with lichen planus.
Arias-Santiago S, Buendía-Eisman A, Aneiros-Fernández J, Girón-Prieto MS, Gutiérrez-Salmerón MT, Mellado VG, Naranjo-Sintes R.
Am J Med. 2011 Jun;124(6):543-8.
Not a graves' situation.
Ruchala M, Szczepanek E, Puszczewicz M, Sosnowski P, Sowinski J.
Am J Med. 2011 Mar;124(3):210-4. No abstract available.
Cardiovascular comorbidities of type 2 diabetes mellitus: defining the potential of glucagonlike peptide-1-based therapies.
Chilton R, Wyatt J, Nandish S, Oliveros R, Lujan M.
Am J Med. 2011 Jan;124(1 Suppl):S35-53. Review.
Treating mixed hyperlipidemia and the atherogenic lipid phenotype for prevention of cardiovascular events.
Rubenfire M, Brook RD, Rosenson RS.
Am J Med. 2010 Oct;123(10):892-8. Review.
Office management of peripheral arterial disease.
Aronow WS.
Am J Med. 2010 Sep;123(9):790-2.
Hyponatremia and pseudohyponatremia: first, do no harm.
Lippi G, Aloe R.
Am J Med. 2010 Sep;123(9):e17. No abstract available.
Health insurance and cardiovascular disease risk factors.
Brooks EL, Preis SR, Hwang SJ, Murabito JM, Benjamin EJ, Kelly-Hayes M, Sorlie P, Levy D.
Am J Med. 2010 Aug;123(8):741-7.
Confronting the type 2 diabetes epidemic: the emerging role of incretin-based therapies.
Fonseca VA, Zinman B, Nauck MA, Goldfine AB, Plutzky J.
Am J Med. 2010 Jul;123(7):S2-S10.
Effects of incretin hormones on beta-cell mass and function, body weight, and hepatic and myocardial function.
Mudaliar S, Henry RR.
Am J Med. 2010 Mar;123(3 Suppl):S19-27. Review.
Higher incidence of mild cognitive impairment in familial hypercholesterolemia.
Zambón D, Quintana M, Mata P, Alonso R, Benavent J, Cruz-Sánchez F, Gich J, Pocoví M, Civeira F, Capurro S, Bachman D, Sambamurti K, Nicholas J, Pappolla MA.
Am J Med. 2010 Mar;123(3):267-74.
Care of the cancer survivor: metabolic syndrome after hormone-modifying therapy.
Redig AJ, Munshi HG.
Am J Med. 2010 Jan;123(1):87.e1-6. Review.
Statins decrease the occurrence of venous thromboembolism in patients with cancer.
Khemasuwan D, Divietro ML, Tangdhanakanond K, Pomerantz SC, Eiger G.
Am J Med. 2010 Jan;123(1):60-5.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on